MetaCap

Generate Biomedicines (GENB) News

NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.54-0.83 (-8.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

GENB news summary

We found 9 recent headlines mentioning Generate Biomedicines (GENB): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. GENB is making an outsized move today, down 8.00% at $9.54, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Generate Biomedicines, Inc. reports Q3 results", was published by Seeking Alpha on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Generate Biomedicines headlines

Stocks mentioned alongside GENB

Compare GENB